1 recruiting, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
Follow Coronary Artery Disease Progression: new trials by email Literature Review of Coronary Artery Disease Progression trials Research Report on Coronary Artery Disease Progression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis Rosuvastatin 20 Mg Oral Tablet, Colchicine 0.5 MG Oral Tablet Once Daily, Placebo - Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression | Phase 3 | Recruiting | Duke University | 1500 | 2026-07-21 | 2026-10-07 |
| Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease Quercetin - Coronary Artery Disease Progression | Phase 3 | Unknown | InCor Heart Institute | 60 | 2019-08-02 | 2019-10-04 |
Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Heart Diseases (1) · Myocardial Ischemia (1) · Vascular Diseases (1)
Atorvastatin (1) · Colchicine (1) · Quercetin (1) · Rosuvastatin Calcium (1) · Tablets (1)
Duke University (1) · InCor Heart Institute (1)
Brazil (1) · United States (1)
UG3HL181434 (1)